Elucidation of neurophysin-bioligand interactions from molecular modeling

• Autorzy: Kazmierkiewicz R. , Czaplewski C. , Ciarkowski J.
• Języki publikacji: EN

Abstrakty

EN

This is a review of our recent modeling work aimed at: (i) development and assessment of techniques for reliable refinement of low-resolution protein structures and (ii) using these techniques, at solving specific problems perti­nent to neurophysin-bioligand interactions. Neurophysins 1 and II (NPI and NPII) serve in the neurosecretory granules of the posterior pituitary as carrier proteins for the neurophyseal hormones oxytocin (OT) and vasopressin (VP), respectively, until the latter are released into blood. NPs are homologous two-domain, sulphur rich small proteins (93-95 residues, 7 disulphide bridges per monomer), capable of being aggregated. The Ca symmetrical NPI2 and NPII2 homodimers, and the (NPI/OT)2 and (NPII/VP)2 heterotetramers, all believed to be the smallest functional units, were modeled using low-resolution struc­ture information, i.e. the C"-carbon coordinates of the homologous NPII/dipep- tide complex as a template. The all-atom representations of the models were obtained using the SYBYL suite of programs (by Tripos, Inc.). Subsequently, they were relaxed, using a constrained simulated annealing (CSA) protocol, and submitted to about 100 ps molecular dynamics (MD) in water, using the AMBER 4.1 force field. The (NPI/OThand (NPII/VP)2 structures, averaged after the last 20 ps of MD, were remarkably similar to those recently reported either for NPII/dipeptide or NPlI/oxytocin complex in the solid state (Chen et al., 1991, Proc. Natl. Acad. Sci., U.S.A. 88,4240-4244; Rose et al, 1996, Nature Struct. Biol. 3, 163-169). The results indicate that the 3io helices (terminating the amino domains) and the carboxyl domains are more mobile than the remainder of the NP monomers. The hormones become anchored by residues 1-3 and 6 to the host, leaving residues 4-5 and 7-9 exposed on the surface and free to move. A cluster of attractive interactions, extending from the ligand binding site, Tyr- 24-Ile-26 of unit 1(2), to the inter-monomer interface Val-36 of unit 1(2), Cys-79 and Ile-72 of unit 2(1), is clearly seen. We suggest that both these interactions as well as the increased mobility of the 3 10 helix and the carboxyl domain may contribute to the allosteric communication between the ligand and the unitl- unit2 interface.REFERENCES

Słowa kluczowe

EN

allosteric communication; molecular dynamics; protein-ligand interaction

• Wydawca: -
• Czasopismo: Acta Biochimica Polonica
• Rocznik: 1997
• Tom: 44
• Numer: 3
• Opis fizyczny: p.453-466,fig.

Twórcy

autor

Kazmierkiewicz R.

• University of Gdansk, J.Sobieskiego 18, 80-952 Gdansk, Poland

autor

Czaplewski C.

autor

Ciarkowski J.

Bibliografia

• 1. Land, H., Grez, M., Ruppert, S., Schmale, H., Rehbcin, M., Richter, D. & Schutz, G. (1983) Deduced amino acid sequence from the bovine oxytocin-neurophysin 1 precursor cDNA. Na­ture 302. 342-344.2. Land. H., Schutz, G., Schmale, H. & Richter, I). (1982) Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin-neuro- physin II precursor. Nature 295, 29&-303.
• 3. Drcifuss, J.J. (1975) A review of neurosecre­tory granules: Their contents and mechanism of release. Ann. N. Y. Acad. Sci. 248,184-201.
• 4. Breslow, E. & Burman, S. (1990) Molecular, thermodynamic, and biological aspects of rec­ognition and function in neurophysin-hor- mone systems: A model system for the analy­sis of protein-peptide interactions. Adv. Enzy- mol. 63, 1-67.
• 5. Breslow, E. & Walter, R. (1972) Binding prop­erties of bovine neurophysin I and II: An equilibrium dialysis study. Molecular Phar­macology 8, 5-81.
• 6. Breslow, E. (1978) Chemistry and biology of the neurophysins. Annu. Rev. Biochem. 48, 251-274.
• 7. Menendez-Botet, C. & Breslow, E. (1975) Chemical and physical properties of the disul- phides of bovine neurophysin-II. Biochemistry 14, 3825-3835.
• 8. Chaiken, I.M., Randolph, R.E. & Taylor, H.C. (1975) Conformational effects associated with the interaction of polypeptide ligands with neurophysins. Ann. N.Y. Acad. Sci. 248, 442-450.
• 9. Kanmera, T. & Chaiken, l.M. (1985) Molecu­lar properties of the oxytocin/bovine neuro­physin I biosynthetic precursor. Studies us­ing a semisynthetic precursor. J. Biol. Chem. 260, 8474-8482.
• 10. Ando, S., McPhie, P. & Chaiken, l.M. (1987) Sequence redesign and the assembly mecha­nism of the oxytocin/bovine neurophysin I biosynthetic precursor. J. Biol.Chem. 262, 12962-12969.
• 11. Huang, H.B. & Breslow, E. (1992) Identifica­tion of the unstable neurophysin disuiphidc and localization to the hormone-binding site. Relationship to folding-unfolding pathways. J. Biol. Chem. 267, 6750-6756.
• 12. Chen, L., Rose, J.P., Breslow, E., Yang, D.f Chang, W.-E., Furey, W.F., Jr., Sax, M. & Wang, B.-C. (1991) Crystal structure of a bovine neurophysin II dipeptide complex at 2.8 A determined from the single-wavelength anomalous scattering signal of an incorpo­rated iodine atom. Proc. Natl. Acad. Sci. U.S.A. 88, 4240-^1244.
• 13. Rose, J.P., Wu, Ch.-K., Hsiao, Ch.-D., Bres­low, E. & Wang, B.-C. (1996) Crystal struc­ture of the neurophysin-oxytocin complex. Nature Struct. Biol. 3, 163-169.
• 14. Kaźmierkiewicz, R., Czapiewski, C., Lam- mek, B. Ciarkowski. J. & Lesyng, B. (1995) Study of the interactions between neuro­physin II and dipeptide ligand by means of molecular dynamics. J. Mol. Model. 1, 135- -141.
• 15. Bernstein, F.C., Koetzle, T.F., Williams, G.J., Meyer, E.E.J., Brice, M.D., Rodgers, J.R., Kennard, O., Shimanouchi, T. & Tsanumi, M. (1977) The protein data bank: A computer- based archive file for macromolecular struc­tures. J. Mol. Biol. 112, 535-542.
• 16. Kaźmierkiewicz, R., Czapiewski, C., Lam- mek, B. & Ciarkowski, J. (1997) Molecular modeling of the neurophysin I/oxytocin com­plex. J. Comp. Aided Molec. Design 11, 9-20.
• 17. Kaźmierkiewicz, R., Czapiewski, C., Lam- mek, B. & Ciarkowski, J. (1997) Molecular modeling of the neurophysin II/vasopressin complex. Quant. Struct.-Act. Re lat. 16. 193-200.
• 18. SYBYL, v. 6.1 (1994) Tripos Inc.. St. Louis, MO, U.S.A.
• 19. Lippens, G., Hallenga, K.. Van Belle, D., Wo- dak, S.J., Nirmala, N.R., Hill, P., Russell, K.C., Smith, D.D. & Hruby, V. (1993) Transfer nuclear Overhauser effect study of the confor­mation of oxytocin bound to bovine neuro­physin I. J. Am. Chem. Soc. 32, 9423-9434.
• 20. Breslow, E., Sardana, V., Deeb, R., Barbar, E. & Peyton, D.H. (1995) NMR behavior of the aromatic protons of bovine neurophysin-I and its peptide complexes: Implications for solu­tion structure and for function. Biochemistry 34,2137-2147.
• 21. Pearlman, D.A, Case, D.A., Caldwell, J.W., Ross, W.S., Cheatham III, T.E., Ferguson, D.M., Seibel, G.L., Singh, U.C., Weiner, P.K. & Kollman, P.A. (1995) AMBER 4.1. Univer­sity of California, San Francisco, CA, U.S.A.
• 22. Sayle, R. (1996) RasMol v. 2.6. Molecular Visualisation Program, Glaxo Wellcome Re­search and Development, Stevenage, Hert­fordshire, U.K.
• 23. Kraulis, P. (1991) MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24. 946-950.